08858643 · Active · incorporated 12 years, 6 months ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Series B+
Develops cancer treatments by mining the genetic code to enable the immune system to kill cancer cells.
See the complete cap table with every shareholder, founder tags, dilution across 14 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.